People · Operator
Named in public records as an officer, director or promoter · active 2010–2010 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Vivaldi Biosciences Inc | — | Biotechnology | Seed | $2.0M | $87.7M | 2010 |
Douglass Given at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Douglass Given on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Georg Nebgen | 1 | 5 |
| William Gerber | 1 | 3 |
| Vic Schmitt | 1 | 2 |
| David Liebowitz | 1 | 2 |
| Peter Johann | 1 | 2 |
| Elliott O. Kieff, M.D. | 1 | 1 |
| Peter O. Palese, Ph.D. | 1 | 1 |
| William O. Wick, Jr. | 1 | 1 |
| Adolfo O. Garcia-Sastre, Ph.D. | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.